il1 β Search Results


92
MedChemExpress il 1β
Scu attenuated colonic inflammation in DSS-treated mice. (A) MPO activity in colon tissues from Veh- and DSS-treated mice, administered with Scu and 5-ASA. (B–F) Quantitative RT-PCR analysis of mRNA levels of Tnf-α (B) <t>,</t> <t>Il-1β</t> (C) , Il-1α (D) , Cxcl1 (E) , and Il-6 (F) , respectively, in colon tissues from different groups of mice. Data are presented as the mean ± SEM. N = 6 mice; **, p < 0.01 vs. Veh; # , p < 0.05, ## , p < 0.01 vs. DSS. One-way ANOVA with Bonferroni’s multiple comparisons tests.
Il 1β, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/IL-1+beta%2C+Human/pmc11536309-44-9-15
Average 92 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

97
TargetMol il 1β
<t>IL-1β</t> <t>promoted</t> tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001
Il 1β, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/IL-1+beta-IL-1F2+Protein%2C+Mouse%2C+Recombinant/pmc11936857-38-14-17
Average 97 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

86
Servicebio Inc immunohistochemical interleukin il
Histology and <t>IL-2</t> expression in rat hemorrhoidal tissue. A Microscopic appearance of the hemorrhoid areas of the rats in each group (HE, ×50; a model group, b control group). B Expression of IL-2 in anorectal tissue in each group detected by immunohistochemical staining. (IHC, ×50; a model group, b control group)
Immunohistochemical Interleukin Il, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/1+anti+il+%CE%B2/pmc13031196-64-85-90
Average 86 stars, based on 1 article reviews
immunohistochemical interleukin il - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

95
Proteintech il 1β
Histology and <t>IL-2</t> expression in rat hemorrhoidal tissue. A Microscopic appearance of the hemorrhoid areas of the rats in each group (HE, ×50; a model group, b control group). B Expression of IL-2 in anorectal tissue in each group detected by immunohistochemical staining. (IHC, ×50; a model group, b control group)
Il 1β, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/Human+IL-1+beta+ELISA+Kit/pmc06966172-43-7-8
Average 95 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Proteintech il 6
OXA activated TLR4 signaling in ESCC cells. The cells were treated by OXA (25 µM) for 24 h. A , B . The mRNA expressions of TLR4 and MYD88 in ESCC cell lines and normal esophageal cells were detected by qRT-PCR. C . ICC showed the immunocytochemical activity of NF-κB p65, p-NF-κB p65, COX-2, and MYD88. Scale bar: 50 μm. D . qRT-PCR analysis of mRNA levels of IL-1β, <t>IL-6,</t> COX-2, CXCL5, and CXCL8. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group
Il 6, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/Mouse+IL-1+beta+ELISA+Kit/pmc12990394-76-3-9
Average 96 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Proteintech biomarkers serum interleukin 1 beta
OXA activated TLR4 signaling in ESCC cells. The cells were treated by OXA (25 µM) for 24 h. A , B . The mRNA expressions of TLR4 and MYD88 in ESCC cell lines and normal esophageal cells were detected by qRT-PCR. C . ICC showed the immunocytochemical activity of NF-κB p65, p-NF-κB p65, COX-2, and MYD88. Scale bar: 50 μm. D . qRT-PCR analysis of mRNA levels of IL-1β, <t>IL-6,</t> COX-2, CXCL5, and CXCL8. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group
Biomarkers Serum Interleukin 1 Beta, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/Rat+IL-1+beta+ELISA+Kit/pm31475167-93-5-20
Average 95 stars, based on 1 article reviews
biomarkers serum interleukin 1 beta - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
MedChemExpress interleukin 1β il 1β treatment
Bufalin attenuated macrophage pyroptosis and <t>reduced</t> <t>IL-1β</t> release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )
Interleukin 1β Il 1β Treatment, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/Animal-Free+IL-1+beta%2C+Human/pmc12043737-83-1-8
Average 94 stars, based on 1 article reviews
interleukin 1β il 1β treatment - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress il1β
Bufalin attenuated macrophage pyroptosis and <t>reduced</t> <t>IL-1β</t> release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )
Il1β, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/IL-1+beta%2C+Human/pmc13355504-30-0-2
Average 94 stars, based on 1 article reviews
il1β - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Revvity human il 1β elisa kit
Bufalin attenuated macrophage pyroptosis and <t>reduced</t> <t>IL-1β</t> release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )
Human Il 1β Elisa Kit, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/AlphaPlex-545+Human+IL1%CE%B2+Detection+Kit%2C+100+assay+points/pmc08272460-46-6-14
Average 90 stars, based on 1 article reviews
human il 1β elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
TargetMol il 1 beta il 1f2 protein human recombinant his
Bufalin attenuated macrophage pyroptosis and <t>reduced</t> <t>IL-1β</t> release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )
Il 1 Beta Il 1f2 Protein Human Recombinant His, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il1+%CE%B2/IL-1+beta%2FIL-1F2+Protein%2C+Human%2C+Recombinant/pm42956743-882-70-76
Average 94 stars, based on 1 article reviews
il 1 beta il 1f2 protein human recombinant his - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Scu attenuated colonic inflammation in DSS-treated mice. (A) MPO activity in colon tissues from Veh- and DSS-treated mice, administered with Scu and 5-ASA. (B–F) Quantitative RT-PCR analysis of mRNA levels of Tnf-α (B) , Il-1β (C) , Il-1α (D) , Cxcl1 (E) , and Il-6 (F) , respectively, in colon tissues from different groups of mice. Data are presented as the mean ± SEM. N = 6 mice; **, p < 0.01 vs. Veh; # , p < 0.05, ## , p < 0.01 vs. DSS. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Journal: Frontiers in Pharmacology

Article Title: Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption

doi: 10.3389/fphar.2024.1479441

Figure Lengend Snippet: Scu attenuated colonic inflammation in DSS-treated mice. (A) MPO activity in colon tissues from Veh- and DSS-treated mice, administered with Scu and 5-ASA. (B–F) Quantitative RT-PCR analysis of mRNA levels of Tnf-α (B) , Il-1β (C) , Il-1α (D) , Cxcl1 (E) , and Il-6 (F) , respectively, in colon tissues from different groups of mice. Data are presented as the mean ± SEM. N = 6 mice; **, p < 0.01 vs. Veh; # , p < 0.05, ## , p < 0.01 vs. DSS. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Article Snippet: BAY11-7085 (Cat# HY-10257), 5-aminosalicylic acid (5-ASA, Cat# HY-15027), and IL-1β (Cat# HY-P78459A) were obtained from MedChemExpress (Monmouth Junction, NJ, United States).

Techniques: Activity Assay, Quantitative RT-PCR

Scu inhibited IL-1β-induced mRNA expression of inflammatory mediators and barrier damage of HT-29 cells. (A) HT-29 cell viability measured by the MTT assay after being exposed to different concentrations of Scu for 24 h (B, C) Quantitative RT-PCR analysis of mRNA levels of IL-6 (B) and IL-8 (C) in HT-29 cells treated with IL-1β (10 ng/mL) for 12 h in the absence and presence of Scu (10 μM). (D) Change in the TEER of HT-29 monolayer treated with IL-1β (10 ng/mL, 24 h) in the absence and presence of Scu (10 μM). (E) Representative immunofluorescence images of E-cadherin (upper panel), occludin (middle panel), and ZO-1 (lower panel) in HT-29 cells after being exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. (F) Representative Western blots of E-cadherin, occludin, and ZO-1 in HT-29 cells exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). (G) Quantification of E-cadherin, occludin, and ZO-1 protein expression in HT-29 cells after being exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). Data are expressed as the mean ± SEM. N = 5–6; **, p < 0.01 vs. Veh (0.1% DMSO); # , p < 0.05, ## , p < 0.01 vs. IL-1β. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Journal: Frontiers in Pharmacology

Article Title: Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption

doi: 10.3389/fphar.2024.1479441

Figure Lengend Snippet: Scu inhibited IL-1β-induced mRNA expression of inflammatory mediators and barrier damage of HT-29 cells. (A) HT-29 cell viability measured by the MTT assay after being exposed to different concentrations of Scu for 24 h (B, C) Quantitative RT-PCR analysis of mRNA levels of IL-6 (B) and IL-8 (C) in HT-29 cells treated with IL-1β (10 ng/mL) for 12 h in the absence and presence of Scu (10 μM). (D) Change in the TEER of HT-29 monolayer treated with IL-1β (10 ng/mL, 24 h) in the absence and presence of Scu (10 μM). (E) Representative immunofluorescence images of E-cadherin (upper panel), occludin (middle panel), and ZO-1 (lower panel) in HT-29 cells after being exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. (F) Representative Western blots of E-cadherin, occludin, and ZO-1 in HT-29 cells exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). (G) Quantification of E-cadherin, occludin, and ZO-1 protein expression in HT-29 cells after being exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of Scu (10 μM). Data are expressed as the mean ± SEM. N = 5–6; **, p < 0.01 vs. Veh (0.1% DMSO); # , p < 0.05, ## , p < 0.01 vs. IL-1β. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Article Snippet: BAY11-7085 (Cat# HY-10257), 5-aminosalicylic acid (5-ASA, Cat# HY-15027), and IL-1β (Cat# HY-P78459A) were obtained from MedChemExpress (Monmouth Junction, NJ, United States).

Techniques: Expressing, MTT Assay, Quantitative RT-PCR, Immunofluorescence, Staining, Western Blot

Scu inhibited IL-1β-induced phosphorylation of NF-κB and its nuclear translocation in HT-29 cells. (A) Representative Western blots and (B) quantification of phosphorylated NF-κB in HT-29 cells. HT-29 cells were exposed to IL-1β (10 ng/mL) in the absence and presence of Scu (10 μM). (C) Representative immunofluorescence images of stained with NF-κB in HT-29 cells. Cells were treated with IL-1β (10 ng/mL) for 30 min in the absence and presence of Scu (10 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. (D, E) Quantitative RT-PCR analysis of mRNA levels of IL-6 (D) and IL-8 (E) in HT-29 cells treated with IL-1β (10 ng/mL) for 12 h in the absence and presence of BAY11-7082 (3 μM). (F) Changes in the TEER of HT-29 monolayer treated with IL-1β (10 ng/mL) for 24 h in the absence and presence of BAY11-7082 (3 μM). (G) Representative immunofluorescence images of E-cadherin, occludin, and ZO-1 in HT-29 cells exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of BAY11-7085 (3 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. N = 3–6. **, p < 0.01 vs. Veh; # , p < 0.05, ## , p < 0.01 vs. IL-1β. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Journal: Frontiers in Pharmacology

Article Title: Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption

doi: 10.3389/fphar.2024.1479441

Figure Lengend Snippet: Scu inhibited IL-1β-induced phosphorylation of NF-κB and its nuclear translocation in HT-29 cells. (A) Representative Western blots and (B) quantification of phosphorylated NF-κB in HT-29 cells. HT-29 cells were exposed to IL-1β (10 ng/mL) in the absence and presence of Scu (10 μM). (C) Representative immunofluorescence images of stained with NF-κB in HT-29 cells. Cells were treated with IL-1β (10 ng/mL) for 30 min in the absence and presence of Scu (10 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. (D, E) Quantitative RT-PCR analysis of mRNA levels of IL-6 (D) and IL-8 (E) in HT-29 cells treated with IL-1β (10 ng/mL) for 12 h in the absence and presence of BAY11-7082 (3 μM). (F) Changes in the TEER of HT-29 monolayer treated with IL-1β (10 ng/mL) for 24 h in the absence and presence of BAY11-7082 (3 μM). (G) Representative immunofluorescence images of E-cadherin, occludin, and ZO-1 in HT-29 cells exposed to IL-1β (10 ng/mL) for 24 h in the absence and presence of BAY11-7085 (3 μM). Nuclei were stained with Hoechst 33342. Scale bar = 10 μm. N = 3–6. **, p < 0.01 vs. Veh; # , p < 0.05, ## , p < 0.01 vs. IL-1β. One-way ANOVA with Bonferroni’s multiple comparisons tests.

Article Snippet: BAY11-7085 (Cat# HY-10257), 5-aminosalicylic acid (5-ASA, Cat# HY-15027), and IL-1β (Cat# HY-P78459A) were obtained from MedChemExpress (Monmouth Junction, NJ, United States).

Techniques: Phospho-proteomics, Translocation Assay, Western Blot, Immunofluorescence, Staining, Quantitative RT-PCR

IL-1β promoted tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC

doi: 10.1007/s00262-025-04015-1

Figure Lengend Snippet: IL-1β promoted tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Article Snippet: Tregs induced by naive CD4+T cells from the spleen of C57BL/6 mice, treated with IL-1β (50 ng/ml, TargetMol, #TMPY-02134).

Techniques: Isolation, Injection, Flow Cytometry, Expressing, Recombinant

IL-1β promoted the expression of the CTLA4 by regulating NR4A1. A Representative mIHC staining of CD4 (green), FOXP3 (red), IL1R2 (violet), IL-1β (cyan) in human HNSCC tissues. Tregs (yellow) were identified using colocalization of CD4 and FOXP3. Intensity of IL1R2+Treg (violet) and IL-1β (cyan) was calculated using ImageJ according to the line on picture. Scale bar, left, 20 μm; right, 10 μm. B Flow Cytometry showing the expression of IL1R2 in Tregs after treating with recombinant murine IL-1β for 12 h. C Volcano Plot showing significant down-regulated and up-regulated nuclear protein after treating with rmIL-1β (50 ng/mL) measured by Pro DIA quantitative proteomics. D Venn diagram showed 16 genes both up-regulated significantly in rmIL-1β group and worked as transcription factor. E , F The expression of CTLA4 in Tregs after using DIM-C-pPhOH (NR4A1 inhibitor, 20 μM, 24 h) and 4μ8C (IRE1 inhibitor, 200 nM, 24 h) with (F) or without (E) treating with rmIL-1β. G The expression of NR4A1 in nucleus in Tregs after stimulating with rmIL-1β or blocking IL1R2. H The location and intensity of NR4A1 in Tregs with different treatments. Scale bar, left, 2 μm; right, 1 μm. Intensity of NR4A1 (red) and DAPI (blue) was calculated using ImageJ according to the line on picture. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC

doi: 10.1007/s00262-025-04015-1

Figure Lengend Snippet: IL-1β promoted the expression of the CTLA4 by regulating NR4A1. A Representative mIHC staining of CD4 (green), FOXP3 (red), IL1R2 (violet), IL-1β (cyan) in human HNSCC tissues. Tregs (yellow) were identified using colocalization of CD4 and FOXP3. Intensity of IL1R2+Treg (violet) and IL-1β (cyan) was calculated using ImageJ according to the line on picture. Scale bar, left, 20 μm; right, 10 μm. B Flow Cytometry showing the expression of IL1R2 in Tregs after treating with recombinant murine IL-1β for 12 h. C Volcano Plot showing significant down-regulated and up-regulated nuclear protein after treating with rmIL-1β (50 ng/mL) measured by Pro DIA quantitative proteomics. D Venn diagram showed 16 genes both up-regulated significantly in rmIL-1β group and worked as transcription factor. E , F The expression of CTLA4 in Tregs after using DIM-C-pPhOH (NR4A1 inhibitor, 20 μM, 24 h) and 4μ8C (IRE1 inhibitor, 200 nM, 24 h) with (F) or without (E) treating with rmIL-1β. G The expression of NR4A1 in nucleus in Tregs after stimulating with rmIL-1β or blocking IL1R2. H The location and intensity of NR4A1 in Tregs with different treatments. Scale bar, left, 2 μm; right, 1 μm. Intensity of NR4A1 (red) and DAPI (blue) was calculated using ImageJ according to the line on picture. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Article Snippet: Tregs induced by naive CD4+T cells from the spleen of C57BL/6 mice, treated with IL-1β (50 ng/ml, TargetMol, #TMPY-02134).

Techniques: Expressing, Staining, Flow Cytometry, Recombinant, Quantitative Proteomics, Blocking Assay

Histology and IL-2 expression in rat hemorrhoidal tissue. A Microscopic appearance of the hemorrhoid areas of the rats in each group (HE, ×50; a model group, b control group). B Expression of IL-2 in anorectal tissue in each group detected by immunohistochemical staining. (IHC, ×50; a model group, b control group)

Journal: Techniques in Coloproctology

Article Title: Comparison of the modeling effects between two hemorrhoid models

doi: 10.1007/s10151-026-03303-x

Figure Lengend Snippet: Histology and IL-2 expression in rat hemorrhoidal tissue. A Microscopic appearance of the hemorrhoid areas of the rats in each group (HE, ×50; a model group, b control group). B Expression of IL-2 in anorectal tissue in each group detected by immunohistochemical staining. (IHC, ×50; a model group, b control group)

Article Snippet: The study’s experimental pharmaceuticals and reagents included croton oil (GlpBio 1), olive oil (Sinopharm Chemical Reagent Co., Ltd., 20230807); pyridine (Xilong Scientific Co., Ltd., 240507D1); ether (Tianjin Kemiou Chemical Reagent Co., Ltd., 20230919); 2% isoflurane (RWD Life Science Co., Ltd., 20240902); 4% paraformaldehyde (biosharp BL539A); hematoxylin eosin high definition constant staining kit (Servicebio G1076); bovine serum albumin BSA (Servicebio GC305010 ); normal rabbit serum (concentrated type) (Servicebio G1209); histochemical kit DAB chromogenic reagent (Servicebio G1212); immunohistochemical tumor necrosis factor alpha (TNFα) primary antibody (Servicebio AF7014); immunohistochemical interleukin (IL)-2 primary antibody (Servicebio AF5105); immunohistochemical IL-6 primary antibody (Servicebio DF6087); RIPA lysate (Servicebio G2002-100ML); WB TNFα primary antibody (Servicebio GB12188-100); WB IL-2 primary antibody (Servicebio GB11114-100); WB IL-6 primary antibody (Servicebio GB11117-100); HRP goat anti-rabbit secondary antibody (Servicebio GB23303); HRP goat anti-mouse secondary antibody (Servicebio GB23301); prestained protein marker VII (Servicebio G2087-250UL); RNA extraction solution (Servicebio G3013); isopropanol (Sinopharm Chemical Reagent Co., Ltd., 80109218); absolute ethanol (Sinopharm Chemical Reagent Co., Ltd., 10009218); RNA lysis solution (Servicebio G3029); SweScript All-in-One RT SuperMix for qPCR (Servicebio G3337); 2 × universal blue SYBR Green qPCR Master Mix (Servicebio G3326).

Techniques: Expressing, Control, Immunohistochemical staining, Staining

Immunohistochemical overview of anorectal cytokine expression. Expression of A IL-2, B IL-6, C , and D TNFα in anorectal tissue in each group detected by immunohistochemical staining (IHC, ×50; a model group, b control group)

Journal: Techniques in Coloproctology

Article Title: Comparison of the modeling effects between two hemorrhoid models

doi: 10.1007/s10151-026-03303-x

Figure Lengend Snippet: Immunohistochemical overview of anorectal cytokine expression. Expression of A IL-2, B IL-6, C , and D TNFα in anorectal tissue in each group detected by immunohistochemical staining (IHC, ×50; a model group, b control group)

Article Snippet: The study’s experimental pharmaceuticals and reagents included croton oil (GlpBio 1), olive oil (Sinopharm Chemical Reagent Co., Ltd., 20230807); pyridine (Xilong Scientific Co., Ltd., 240507D1); ether (Tianjin Kemiou Chemical Reagent Co., Ltd., 20230919); 2% isoflurane (RWD Life Science Co., Ltd., 20240902); 4% paraformaldehyde (biosharp BL539A); hematoxylin eosin high definition constant staining kit (Servicebio G1076); bovine serum albumin BSA (Servicebio GC305010 ); normal rabbit serum (concentrated type) (Servicebio G1209); histochemical kit DAB chromogenic reagent (Servicebio G1212); immunohistochemical tumor necrosis factor alpha (TNFα) primary antibody (Servicebio AF7014); immunohistochemical interleukin (IL)-2 primary antibody (Servicebio AF5105); immunohistochemical IL-6 primary antibody (Servicebio DF6087); RIPA lysate (Servicebio G2002-100ML); WB TNFα primary antibody (Servicebio GB12188-100); WB IL-2 primary antibody (Servicebio GB11114-100); WB IL-6 primary antibody (Servicebio GB11117-100); HRP goat anti-rabbit secondary antibody (Servicebio GB23303); HRP goat anti-mouse secondary antibody (Servicebio GB23301); prestained protein marker VII (Servicebio G2087-250UL); RNA extraction solution (Servicebio G3013); isopropanol (Sinopharm Chemical Reagent Co., Ltd., 80109218); absolute ethanol (Sinopharm Chemical Reagent Co., Ltd., 10009218); RNA lysis solution (Servicebio G3029); SweScript All-in-One RT SuperMix for qPCR (Servicebio G3337); 2 × universal blue SYBR Green qPCR Master Mix (Servicebio G3326).

Techniques: Immunohistochemical staining, Expressing, Staining, Control

Relative mRNA expression of pro-inflammatory cytokines A IL-2, B IL-6, and C TNFα in anorectal tissue in each group. * P < 0.05 vs control group

Journal: Techniques in Coloproctology

Article Title: Comparison of the modeling effects between two hemorrhoid models

doi: 10.1007/s10151-026-03303-x

Figure Lengend Snippet: Relative mRNA expression of pro-inflammatory cytokines A IL-2, B IL-6, and C TNFα in anorectal tissue in each group. * P < 0.05 vs control group

Article Snippet: The study’s experimental pharmaceuticals and reagents included croton oil (GlpBio 1), olive oil (Sinopharm Chemical Reagent Co., Ltd., 20230807); pyridine (Xilong Scientific Co., Ltd., 240507D1); ether (Tianjin Kemiou Chemical Reagent Co., Ltd., 20230919); 2% isoflurane (RWD Life Science Co., Ltd., 20240902); 4% paraformaldehyde (biosharp BL539A); hematoxylin eosin high definition constant staining kit (Servicebio G1076); bovine serum albumin BSA (Servicebio GC305010 ); normal rabbit serum (concentrated type) (Servicebio G1209); histochemical kit DAB chromogenic reagent (Servicebio G1212); immunohistochemical tumor necrosis factor alpha (TNFα) primary antibody (Servicebio AF7014); immunohistochemical interleukin (IL)-2 primary antibody (Servicebio AF5105); immunohistochemical IL-6 primary antibody (Servicebio DF6087); RIPA lysate (Servicebio G2002-100ML); WB TNFα primary antibody (Servicebio GB12188-100); WB IL-2 primary antibody (Servicebio GB11114-100); WB IL-6 primary antibody (Servicebio GB11117-100); HRP goat anti-rabbit secondary antibody (Servicebio GB23303); HRP goat anti-mouse secondary antibody (Servicebio GB23301); prestained protein marker VII (Servicebio G2087-250UL); RNA extraction solution (Servicebio G3013); isopropanol (Sinopharm Chemical Reagent Co., Ltd., 80109218); absolute ethanol (Sinopharm Chemical Reagent Co., Ltd., 10009218); RNA lysis solution (Servicebio G3029); SweScript All-in-One RT SuperMix for qPCR (Servicebio G3337); 2 × universal blue SYBR Green qPCR Master Mix (Servicebio G3326).

Techniques: Expressing, Control

Western blotting for detecting protein expression of IL-2, IL-6, and TNFα

Journal: Techniques in Coloproctology

Article Title: Comparison of the modeling effects between two hemorrhoid models

doi: 10.1007/s10151-026-03303-x

Figure Lengend Snippet: Western blotting for detecting protein expression of IL-2, IL-6, and TNFα

Article Snippet: The study’s experimental pharmaceuticals and reagents included croton oil (GlpBio 1), olive oil (Sinopharm Chemical Reagent Co., Ltd., 20230807); pyridine (Xilong Scientific Co., Ltd., 240507D1); ether (Tianjin Kemiou Chemical Reagent Co., Ltd., 20230919); 2% isoflurane (RWD Life Science Co., Ltd., 20240902); 4% paraformaldehyde (biosharp BL539A); hematoxylin eosin high definition constant staining kit (Servicebio G1076); bovine serum albumin BSA (Servicebio GC305010 ); normal rabbit serum (concentrated type) (Servicebio G1209); histochemical kit DAB chromogenic reagent (Servicebio G1212); immunohistochemical tumor necrosis factor alpha (TNFα) primary antibody (Servicebio AF7014); immunohistochemical interleukin (IL)-2 primary antibody (Servicebio AF5105); immunohistochemical IL-6 primary antibody (Servicebio DF6087); RIPA lysate (Servicebio G2002-100ML); WB TNFα primary antibody (Servicebio GB12188-100); WB IL-2 primary antibody (Servicebio GB11114-100); WB IL-6 primary antibody (Servicebio GB11117-100); HRP goat anti-rabbit secondary antibody (Servicebio GB23303); HRP goat anti-mouse secondary antibody (Servicebio GB23301); prestained protein marker VII (Servicebio G2087-250UL); RNA extraction solution (Servicebio G3013); isopropanol (Sinopharm Chemical Reagent Co., Ltd., 80109218); absolute ethanol (Sinopharm Chemical Reagent Co., Ltd., 10009218); RNA lysis solution (Servicebio G3029); SweScript All-in-One RT SuperMix for qPCR (Servicebio G3337); 2 × universal blue SYBR Green qPCR Master Mix (Servicebio G3326).

Techniques: Western Blot, Expressing

IL-2, IL-6, and TNFα protein levels in anorectal tissue are significantly elevated in the model group compared to the control group (* P < 0.05). A IL-2, B IL-6, and C TNFα protein expression in anorectal tissue. * P < 0.05 vs control group

Journal: Techniques in Coloproctology

Article Title: Comparison of the modeling effects between two hemorrhoid models

doi: 10.1007/s10151-026-03303-x

Figure Lengend Snippet: IL-2, IL-6, and TNFα protein levels in anorectal tissue are significantly elevated in the model group compared to the control group (* P < 0.05). A IL-2, B IL-6, and C TNFα protein expression in anorectal tissue. * P < 0.05 vs control group

Article Snippet: The study’s experimental pharmaceuticals and reagents included croton oil (GlpBio 1), olive oil (Sinopharm Chemical Reagent Co., Ltd., 20230807); pyridine (Xilong Scientific Co., Ltd., 240507D1); ether (Tianjin Kemiou Chemical Reagent Co., Ltd., 20230919); 2% isoflurane (RWD Life Science Co., Ltd., 20240902); 4% paraformaldehyde (biosharp BL539A); hematoxylin eosin high definition constant staining kit (Servicebio G1076); bovine serum albumin BSA (Servicebio GC305010 ); normal rabbit serum (concentrated type) (Servicebio G1209); histochemical kit DAB chromogenic reagent (Servicebio G1212); immunohistochemical tumor necrosis factor alpha (TNFα) primary antibody (Servicebio AF7014); immunohistochemical interleukin (IL)-2 primary antibody (Servicebio AF5105); immunohistochemical IL-6 primary antibody (Servicebio DF6087); RIPA lysate (Servicebio G2002-100ML); WB TNFα primary antibody (Servicebio GB12188-100); WB IL-2 primary antibody (Servicebio GB11114-100); WB IL-6 primary antibody (Servicebio GB11117-100); HRP goat anti-rabbit secondary antibody (Servicebio GB23303); HRP goat anti-mouse secondary antibody (Servicebio GB23301); prestained protein marker VII (Servicebio G2087-250UL); RNA extraction solution (Servicebio G3013); isopropanol (Sinopharm Chemical Reagent Co., Ltd., 80109218); absolute ethanol (Sinopharm Chemical Reagent Co., Ltd., 10009218); RNA lysis solution (Servicebio G3029); SweScript All-in-One RT SuperMix for qPCR (Servicebio G3337); 2 × universal blue SYBR Green qPCR Master Mix (Servicebio G3326).

Techniques: Control, Expressing

OXA activated TLR4 signaling in ESCC cells. The cells were treated by OXA (25 µM) for 24 h. A , B . The mRNA expressions of TLR4 and MYD88 in ESCC cell lines and normal esophageal cells were detected by qRT-PCR. C . ICC showed the immunocytochemical activity of NF-κB p65, p-NF-κB p65, COX-2, and MYD88. Scale bar: 50 μm. D . qRT-PCR analysis of mRNA levels of IL-1β, IL-6, COX-2, CXCL5, and CXCL8. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group

Journal: BMC Gastroenterology

Article Title: Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis

doi: 10.1186/s12876-026-04663-2

Figure Lengend Snippet: OXA activated TLR4 signaling in ESCC cells. The cells were treated by OXA (25 µM) for 24 h. A , B . The mRNA expressions of TLR4 and MYD88 in ESCC cell lines and normal esophageal cells were detected by qRT-PCR. C . ICC showed the immunocytochemical activity of NF-κB p65, p-NF-κB p65, COX-2, and MYD88. Scale bar: 50 μm. D . qRT-PCR analysis of mRNA levels of IL-1β, IL-6, COX-2, CXCL5, and CXCL8. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control group

Article Snippet: Serum concentrations of IL-6 (JL20268, Jonin) and IL-1β (KE10003, Proteintech) were quantified using commercial ELISA kits according to manufacturers’ protocols.

Techniques: Quantitative RT-PCR, Activity Assay, Control

TLR4 knockout enhances the sensitivity of OXA chemotherapy in ESCC in vivo. A . Number of tumors. B . HE staining of esophageal epithelial tissues. Scale bar: 50 μm. C . Body weight of mice. D , E . the levels of serum IL-1β and IL-6 in mice from different groups were detected by ELISA. F . The immunohistochemical activities of PCNA, CK14, Cyclin D1, COX-2, S100A8 and S100A9 in the esophageal tissue were detected. Scale bar: 100 μm. G , H . The mRNA levels of inflammatory cytokines and glycolysis-related proteins in esophageal tissue were detected by qRT-PCR. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. WT group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. WT + 4NQO + OXA group

Journal: BMC Gastroenterology

Article Title: Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis

doi: 10.1186/s12876-026-04663-2

Figure Lengend Snippet: TLR4 knockout enhances the sensitivity of OXA chemotherapy in ESCC in vivo. A . Number of tumors. B . HE staining of esophageal epithelial tissues. Scale bar: 50 μm. C . Body weight of mice. D , E . the levels of serum IL-1β and IL-6 in mice from different groups were detected by ELISA. F . The immunohistochemical activities of PCNA, CK14, Cyclin D1, COX-2, S100A8 and S100A9 in the esophageal tissue were detected. Scale bar: 100 μm. G , H . The mRNA levels of inflammatory cytokines and glycolysis-related proteins in esophageal tissue were detected by qRT-PCR. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. WT group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. WT + 4NQO + OXA group

Article Snippet: Serum concentrations of IL-6 (JL20268, Jonin) and IL-1β (KE10003, Proteintech) were quantified using commercial ELISA kits according to manufacturers’ protocols.

Techniques: Knock-Out, In Vivo, Staining, Enzyme-linked Immunosorbent Assay, Immunohistochemical staining, Quantitative RT-PCR

Schematic diagram illustrating the mechanism by which TLR4 inhibition enhances oxaliplatin (OXA) chemosensitivity in esophageal squamous cell carcinoma (ESCC). OXA treatment upregulates TLR4 and its downstream adaptor protein MYD88, which activates the phosphorylation of NF-κB p65. This activation drives two parallel pathways: (1) the inflammatory response, characterized by the upregulation of pro-inflammatory factors such as IL-6, COX-2, and CXCL5; (2) the glycolytic metabolic reprogramming, mediated by the HIF-1α/GLUT1 axis and enhanced expression of glycolytic enzymes including PFKM and LDHB. These two pathways synergistically promote ESCC cell proliferation, migration, and invasion, ultimately reducing OXA chemosensitivity. Inhibition of TLR4 (via genetic knockout, shRNA knockdown, or pharmacological inhibitor TAK-242) or its downstream mediator MYD88 (via shRNA knockdown or inhibitor ST2825) blocks NF-κB p65 phosphorylation, thereby suppressing both the inflammatory response and glycolytic activity. This dual inhibition disrupts the adaptive survival mechanisms of ESCC cells, potentiating the anti-tumor efficacy of OXA

Journal: BMC Gastroenterology

Article Title: Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis

doi: 10.1186/s12876-026-04663-2

Figure Lengend Snippet: Schematic diagram illustrating the mechanism by which TLR4 inhibition enhances oxaliplatin (OXA) chemosensitivity in esophageal squamous cell carcinoma (ESCC). OXA treatment upregulates TLR4 and its downstream adaptor protein MYD88, which activates the phosphorylation of NF-κB p65. This activation drives two parallel pathways: (1) the inflammatory response, characterized by the upregulation of pro-inflammatory factors such as IL-6, COX-2, and CXCL5; (2) the glycolytic metabolic reprogramming, mediated by the HIF-1α/GLUT1 axis and enhanced expression of glycolytic enzymes including PFKM and LDHB. These two pathways synergistically promote ESCC cell proliferation, migration, and invasion, ultimately reducing OXA chemosensitivity. Inhibition of TLR4 (via genetic knockout, shRNA knockdown, or pharmacological inhibitor TAK-242) or its downstream mediator MYD88 (via shRNA knockdown or inhibitor ST2825) blocks NF-κB p65 phosphorylation, thereby suppressing both the inflammatory response and glycolytic activity. This dual inhibition disrupts the adaptive survival mechanisms of ESCC cells, potentiating the anti-tumor efficacy of OXA

Article Snippet: Serum concentrations of IL-6 (JL20268, Jonin) and IL-1β (KE10003, Proteintech) were quantified using commercial ELISA kits according to manufacturers’ protocols.

Techniques: Inhibition, Phospho-proteomics, Activation Assay, Expressing, Migration, Knock-Out, shRNA, Knockdown, Activity Assay

Bufalin attenuated macrophage pyroptosis and reduced IL-1β release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )

Journal: Journal of Cardiovascular Translational Research

Article Title: Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway

doi: 10.1007/s12265-024-10577-9

Figure Lengend Snippet: Bufalin attenuated macrophage pyroptosis and reduced IL-1β release into the myocardium and serum during I/R injury. A-C The RNA sequencing data were extracted from GSE 126772. The mRNA levels of Nlrp3 , Pycard ( ASC ) and Il-1b in macrophages isolated from heart after MI were shown as fold change compared to the Pre group (control group, n = 2,3). D Macrophages were identified and isolated from the heart by flow cytometry. E–F Immunoblotting was performed to assess the expression levels of NLRP3, GSDMD and IL-1β in macrophages after I/R injury with or without bufalin treatment. Each target band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Sham + PBS group (control group, n = 3). G Representative IL-1β expression and localization in murine hearts are shown by IHC analysis in longitudinal sections of whole hearts. For each mouse, 5 representative zones in the left ventricle were chosen randomly to determine the percentage of IL-1β-positive ratio by ImageJ ( n = 3). H IL-1β levels in the peripheral blood of mice that were subjected to I/R injury and were treated with or without bufalin were measured by ELISA ( n = 6). IHC (immunohistochemistry). Data are expressed as the mean ± SEM. P values were determined by ordinary one-way ANOVA with Dunnett’s multiple comparisons test ( A - C ) and two-way ANOVA with Tukey’s multiple comparisons test ( F and H )

Article Snippet: For interleukin-1β (IL-1β) treatment, recombinant mouse IL-1β (HY-P7073, MedChemExpress, New Jersey, USA) was added to HL-1 cells at different concentrations (0, 100 pg/ml, 300 pg/ml, 1000 pg/ml) and incubated for 24 h. For anakinra treatment, the recombinant human interleukin-1 receptor (IL-1R) antagonist anakinra (HY-108841, MedChemExpress) was added to cardiomyocytes every 6 h for 24 h when they were cocultured with normoxia-treated or H/R-treated macrophages.

Techniques: RNA Sequencing, Isolation, Control, Flow Cytometry, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Immunohistochemistry

Bufalin attenuated H/R-treated macrophage pyroptosis in vitro. Macrophages were subjected to 1 h of hypoxia and 24 h of reoxygenation treated with PBS or bufalin. A-B Proteins were extracted from cells and immunoblotting analysis was performed. The expressions of NLRP3, GSDMD, and IL-1β were normalized to that of β-actin and then compared with the Sham + PBS group (control group, n = 3). C PI staining was used to examine the plasma membrane integrity of macrophages. Positive cells were counted and normalized to the total number of cells ( n = 5). D Cell viability was assessed by measuring the quantity of ATP in macrophages subjected to different treatments ( n = 3, 6). E IL-1β levels in the culture medium of macrophages were measured by ELISA ( n = 3). Data are presented as the mean ± SEM. P values were calculated by two-way ANOVA with Tukey’s multiple comparisons test ( B , C , and E ) or Šídák’s multiple comparisons test ( D )

Journal: Journal of Cardiovascular Translational Research

Article Title: Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway

doi: 10.1007/s12265-024-10577-9

Figure Lengend Snippet: Bufalin attenuated H/R-treated macrophage pyroptosis in vitro. Macrophages were subjected to 1 h of hypoxia and 24 h of reoxygenation treated with PBS or bufalin. A-B Proteins were extracted from cells and immunoblotting analysis was performed. The expressions of NLRP3, GSDMD, and IL-1β were normalized to that of β-actin and then compared with the Sham + PBS group (control group, n = 3). C PI staining was used to examine the plasma membrane integrity of macrophages. Positive cells were counted and normalized to the total number of cells ( n = 5). D Cell viability was assessed by measuring the quantity of ATP in macrophages subjected to different treatments ( n = 3, 6). E IL-1β levels in the culture medium of macrophages were measured by ELISA ( n = 3). Data are presented as the mean ± SEM. P values were calculated by two-way ANOVA with Tukey’s multiple comparisons test ( B , C , and E ) or Šídák’s multiple comparisons test ( D )

Article Snippet: For interleukin-1β (IL-1β) treatment, recombinant mouse IL-1β (HY-P7073, MedChemExpress, New Jersey, USA) was added to HL-1 cells at different concentrations (0, 100 pg/ml, 300 pg/ml, 1000 pg/ml) and incubated for 24 h. For anakinra treatment, the recombinant human interleukin-1 receptor (IL-1R) antagonist anakinra (HY-108841, MedChemExpress) was added to cardiomyocytes every 6 h for 24 h when they were cocultured with normoxia-treated or H/R-treated macrophages.

Techniques: In Vitro, Western Blot, Control, Staining, Clinical Proteomics, Membrane, Enzyme-linked Immunosorbent Assay

Bufalin restored autophagic flux by suppressing P62 pathway in H/R-induced macrophages. Macrophages were transfected with the p62-overexpression plasmid for 24 h and then subjected to H/R with or without bufalin. A - B The protein levels of P62 were measured by immunoblotting. The bands were normalized to the β-actin band, and the relative expressions were calculated as the fold changes compared to the control group ( n = 3). C The mRNA levels of p62 were measured by qRT‒PCR. The Cq results were normalized to Mus-18 s and then compared with the control group ( n = 3). D-E Proteins were extracted from H/R-treated macrophages that were infected with vector or OE-p62 plasmid in advance and treated with bufalin or PBS. Immunoblotting was performed to measure the expressions of NLRP3, GSDMD and IL-1β. Each band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Con + PBS group (control group, n = 3). F PI staining was used to assess pyroptosis in macrophages. Positive ratios were calculated as the percentage of positive cells compared with total number of cells ( n = 5). G IL-1β levels in the culture medium of macrophages were measured by ELISA ( n = 3). Data are presented as the mean ± SEM. P values were calculated by ordinary one-way ANOVA with Tukey’s multiple comparisons test

Journal: Journal of Cardiovascular Translational Research

Article Title: Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway

doi: 10.1007/s12265-024-10577-9

Figure Lengend Snippet: Bufalin restored autophagic flux by suppressing P62 pathway in H/R-induced macrophages. Macrophages were transfected with the p62-overexpression plasmid for 24 h and then subjected to H/R with or without bufalin. A - B The protein levels of P62 were measured by immunoblotting. The bands were normalized to the β-actin band, and the relative expressions were calculated as the fold changes compared to the control group ( n = 3). C The mRNA levels of p62 were measured by qRT‒PCR. The Cq results were normalized to Mus-18 s and then compared with the control group ( n = 3). D-E Proteins were extracted from H/R-treated macrophages that were infected with vector or OE-p62 plasmid in advance and treated with bufalin or PBS. Immunoblotting was performed to measure the expressions of NLRP3, GSDMD and IL-1β. Each band was normalized to the β-actin band and the relative expression was calculated as the fold change compared to the Con + PBS group (control group, n = 3). F PI staining was used to assess pyroptosis in macrophages. Positive ratios were calculated as the percentage of positive cells compared with total number of cells ( n = 5). G IL-1β levels in the culture medium of macrophages were measured by ELISA ( n = 3). Data are presented as the mean ± SEM. P values were calculated by ordinary one-way ANOVA with Tukey’s multiple comparisons test

Article Snippet: For interleukin-1β (IL-1β) treatment, recombinant mouse IL-1β (HY-P7073, MedChemExpress, New Jersey, USA) was added to HL-1 cells at different concentrations (0, 100 pg/ml, 300 pg/ml, 1000 pg/ml) and incubated for 24 h. For anakinra treatment, the recombinant human interleukin-1 receptor (IL-1R) antagonist anakinra (HY-108841, MedChemExpress) was added to cardiomyocytes every 6 h for 24 h when they were cocultured with normoxia-treated or H/R-treated macrophages.

Techniques: Transfection, Over Expression, Plasmid Preparation, Western Blot, Control, Infection, Expressing, Staining, Enzyme-linked Immunosorbent Assay